Log in
Enquire now
‌

US Patent 7691895 Thrombopoietin activity modulating compounds and methods

Patent 7691895 was granted and assigned to Ligand Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Ligand Pharmaceuticals
Ligand Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7691895
Patent Inventor Names
Todd A. Miller0
Matthew H. McNeill0
Richard J. Penulian0
Thomas Lau0
Bao N. Nguyen0
Daniel A. Ruppar0
Dean P. Phillips0
E. Adam Kallel0
...
Date of Patent
April 6, 2010
Patent Application Number
11937392
Date Filed
November 8, 2007
Patent Primary Examiner
‌
Rebecca L Anderson
Patent abstract

Disclosed herein are compounds of Formula (I), (II), and (III)

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7691895 Thrombopoietin activity modulating compounds and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.